Purpose: The purpose of this work was to determine normal contrast enhancem
ent of the small bowel with biphasic spiral CT, using water as oral contras
t agent.
Method: Biphasic spiral CT was performed in 50 healthy patients undergoing
evaluation as potential renal donors. All patients received 500 ml of water
as oral contrast agent and 150 ml of Omnipaque 350 administered by mechani
cal injector at a rate of 3 ml/s. Dual phase CT of the abdomen was performe
d in each patient. Acquisition of early phase images began 30 s after the s
tart of the intravenous injection, and portal phase images were obtained 60
s after initiation of the contrast agent injection. Attenuation measuremen
ts (in Hounsfield units) were obtained from the wall of the small bowel (du
odenum, jejunum, ileum) in both the arterial and the portal phases.
Results: During the arterial phase, the mean (95% confidence interval) atte
nuation of the duodenum, jejunum, and ileum was 120 (+/- 5), 119 (+/- 5), a
nd 118 (+/- 5) HU, respectively. During the portal phase, the average atten
uation of the duodenum, jejunum, and ileum was 111 (+/- 4), 111 (+/- 3), an
d 107 (+/- 3) HU, respectively. There was no statistically significant diff
erence between the attenuation of the duodenum, jejunum, or ileum within ei
ther the arterial or the portal venous phases. There was a statistically si
gnificant difference in small bowel enhancement between the arterial and po
rtal venous phases.
Conclusion: There is no important variation in small bowel attenuation duri
ng the 30 and 60 s scanning phases. This study serves as a normal reference
that may be helpful when spiral CT is used to evaluate ischemic bowel or i
nflammatory small bowel diseases.